Abstract

Arguably, diabetes mellitus is one of the best quantified human conditions. In the past 50 years, the metabolic monitoring technologies progressed from occasional assessment of average glycemia via HbA, through episodic blood glucose readings, to continuous glucose monitoring (CGM) producing data points every few minutes. The high-temporal resolution of CGM data enabled increasingly intensive treatments, from decision support assisting insulin injection or oral medication, to automated closed-loop control, known as the "artificial pancreas." Throughout this progress, mathematical models and computer simulation of the human metabolic system became indispensable for the technological progress of diabetes treatment, enabling every step, from assessment of insulin sensitivity via the now classic Minimal Model of Glucose Kinetics, to in silico trials replacing animal experiments, to automated insulin delivery algorithms. In this review, we follow these developments, beginning with the Minimal Model, which evolved through the years to become large and comprehensive and trigger a paradigm change in the design of diabetes optimization strategies: in 2007, we introduced a sophisticated model of glucose-insulin dynamics and a computer simulator equipped with a "population" of N = 300 in silico "subjects" with type 1 diabetes. In January 2008, in an unprecedented decision, the Food and Drug Administration (FDA) accepted this simulator as a substitute to animal trials for the pre-clinical testing of insulin treatment strategies. This opened the field for rapid and cost-effective development and pre-clinical testing of new treatment approaches, which continues today. Meanwhile, animal experiments for the purpose of designing new insulin treatment algorithms have been abandoned.

MeSH

Diabetes Mellitus, Research Design, Pancreas, Artificial, Insulin, Computers, Algorithms, Therapeutics, Computer Simulation, Diabetes Mellitus, Type 1, Continuous Glucose Monitoring

Cited by

• Artificial Pancreas: The First 20 Years. J Diabetes Sci Technol, 2025
• Challenges and opportunities in uncertainty quantification for healthcare and biological systems. Philos Trans A Math Phys Eng Sci, 2025
• Human-machine co-adaptation to automated insulin delivery: a randomised clinical trial using digital twin technology. NPJ Digit Med, 2025
• Evaluating Insulin Delivery Systems Using Dynamic Glucose Region Plots and Risk Space Analysis. Sensors (Basel), 2025
• Digital twins are integral to personalizing medicine and improving public health. Nat Rev Gastroenterol Hepatol, 2024
• GLP-1 Receptor Agonists Models for Type 1 Diabetes: A Narrative Review. J Diabetes Sci Technol, 2025
• In Silico Evaluation of Algorithm-Based Clinical Decision Support Systems: Protocol for a Scoping Review. JMIR Res Protoc, 2025
• Metabolic Models, in Silico Trials, and Algorithms. J Diabetes Sci Technol, 2025